Cargando…
Current and future perspectives for Helicobacter pylori treatment and management: From antibiotics to probiotics
Helicobacter pylori (H. pylori) is a Gram-negative anaerobic bacterium that colonizes the human stomach and is the leading cause of gastric diseases such as chronic gastritis and peptic ulcers, as well as the most definite and controllable risk factor for the development of gastric cancer. Currently...
Autores principales: | Liang, Bing, Yuan, Yang, Peng, Xiao-Jin, Liu, Xin-Lin, Hu, Xiao-Kun, Xing, Dong-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732553/ https://www.ncbi.nlm.nih.gov/pubmed/36506013 http://dx.doi.org/10.3389/fcimb.2022.1042070 |
Ejemplares similares
-
Editorial: Helicobacter pylori and its mechanisms of antibiotic survival
por: Krzyżek, Paweł, et al.
Publicado: (2023) -
Editorial: Helicobacter pylori infection and antibiotic resistance: clinical, translational and experimental studies
por: Yadegar, Abbas, et al.
Publicado: (2023) -
Comparative effectiveness of different probiotics supplements for triple helicobacter pylori eradication: a network meta-analysis
por: Wang, Yue, et al.
Publicado: (2023) -
Fighting the Antibiotic Crisis: Flavonoids as Promising Antibacterial Drugs Against Helicobacter pylori Infection
por: González, Andrés, et al.
Publicado: (2021) -
Toxin-Antitoxin Systems - A New Player in Morphological Transformation of Antibiotic-Exposed Helicobacter pylori?
por: Krzyżek, Paweł
Publicado: (2021)